Digital diffraction analysis enables low-cost molecular diagnostics on a smartphone.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 25870273.
- Also identified by DOI 10.1073/pnas.1501815112 and PMC identifier 4426451.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The widespread distribution of smartphones, with their integrated sensors and communication capabilities, makes them an ideal platform for point-of-care (POC) diagnosis, especially in resource-limited settings. Molecular diagnostics, however, have been difficult to implement in smartphones. We herein report a diffraction-based approach that enables molecular and cellular diagnostics. The D3 (digital diffraction diagnosis) system uses microbeads to generate unique diffraction patterns which can be acquired by smartphones and processed by a remote server. We applied the D3 platform to screen for precancerous or cancerous cells in cervical specimens and to detect human papillomavirus (HPV) DNA. The D3 assay generated readouts within 45 min and showed excellent agreement with gold-standard pathology or HPV testing, respectively. This approach could have favorable global health applications where medical access is limited or when pathology bottlenecks challenge prompt diagnostic readouts.
Medical subject headings
- Cell Phone
- Human Papillomavirus DNA Tests
- Papillomavirus Infections
- Precancerous Conditions
- Uterine Cervical Neoplasms